Patent Cliff Looks More Like Mt. Everest for Medco

Published On: November 3rd, 2010

During its third-quarter earnings call today, big PBM Medco Health Solutions gave its new 10-year projections on the generics pipeline, with not-so-muted glee.

Read the rest here:
Patent Cliff Looks More Like Mt. Everest for Medco

STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.

Did you know:

Children from racial and ethnic minority groups continue to lag behind their white peers on measures of health outcomes. Even among children of similar socioeconomic status, minority children fare worse overall

FarhanShabir : Karachi Generate 70% Revenue Of #Pakistan & Gave Its 40% 2 #Punjab But What Karachi Itself Gets In Return? #Discrimination #Pakistan

2012-05-23T17:41:11Z - Reply - View Tweet
Birds0334 : RT @DBSAnsari90: Karachi Generate 70% Revenue Of #Pakistan & Gave Its 40% 2 #Punjab But What Karachi Itself Gets In Return? #Discrimination #Pakistan

2012-05-23T17:41:06Z - Reply - View Tweet
FarhanShabir : RT @khurramfaiz: Karachi Generate 70% Revenue Of #Pakistan & Gave Its 40% 2 #Punjab But What Karachi Itself Gets In Return? #Discrimination #Pakistan

2012-05-23T17:41:03Z - Reply - View Tweet
mqmshahfaisal : RT @khurramfaiz: Karachi Generate 70% Revenue Of #Pakistan & Gave Its 40% 2 #Punjab But What Karachi Itself Gets In Return? #Discrimination #Pakistan

2012-05-23T17:38:26Z - Reply - View Tweet
mqmshahfaisal : RT @DBSAnsari90: Karachi Generate 70% Revenue Of #Pakistan & Gave Its 40% 2 #Punjab But What Karachi Itself Gets In Return? #Discrimination #Pakistan

2012-05-23T17:38:24Z - Reply - View Tweet
DeputyIqbal : RT @khurramfaiz: Karachi Generate 70% Revenue Of #Pakistan & Gave Its 40% 2 #Punjab But What Karachi Itself Gets In Return? #Discrimination #Pakistan

2012-05-23T17:34:05Z - Reply - View Tweet
arsalanali099 : RT @DBSAnsari90: Karachi Generate 70% Revenue Of #Pakistan & Gave Its 40% 2 #Punjab But What Karachi Itself Gets In Return? #Discrimination #Pakistan

2012-05-23T17:27:26Z - Reply - View Tweet

Why Pharma’s Patent Cliff Is Good News for Pharmacies
A bunch of the blockbuster drugs that carried the drug industry for the past decade are about to go off patent. As we’ve noted along with everybody else, that’s going to be tough for pharma companies. (See, for example, the news this week from Pfizer and Bristol-Myers Squibb , which over the next two years..
Drug Price Increases Come As Companies Peer Over Patent Cliff
Drug makers, understandably, don’t like to talk about raising prices. When they must, companies often cite the hefty investment required to develop new treatments, as some do in today’s WSJ article on the pricing issue . But there’s another force that helps explain why 2010′s price increases were the biggest in recent years ..
Eli Lilly Isn’t Planning to Buy Its Way Around the Patent Cliff
Eli Lilly knows a thing or two about the patent cliff: Between now and 2013, patent protection will expire on drugs that account for more than half of its current revenue, this morning’s WSJ notes . ..
AMA Looks to Put Brakes on Debt Load of Med Students
Medical students who went into debt could figure on owing $126,714 in 2007 on average, up from $88,331 in 2000, according to the Association of American Medical Colleges. You can figure the debt tab has only gone up since then ..
What Real Bipartisan Health Care Reform Looks Like » The Foundry
Unlike wages, health coverage is not subject to income or payroll taxes. ..
Baucus: Don’t Like Comparative Effectiveness? Meet ‘Fred’
Most everybody wants the best deal for the money, but not everybody wants to settle for some potential options being excluded from the deal–no matter the cost of those options. So it goes in the continuing debate over comparative effectiveness research in health care. ..

Orshe